Jeannie C. Kelly

ORCID: 0000-0002-4908-4693
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Prenatal Substance Exposure Effects
  • Maternal Mental Health During Pregnancy and Postpartum
  • Maternal and Perinatal Health Interventions
  • Gestational Diabetes Research and Management
  • Maternal and fetal healthcare
  • COVID-19 Impact on Reproduction
  • Opioid Use Disorder Treatment
  • Pregnancy and preeclampsia studies
  • Assisted Reproductive Technology and Twin Pregnancy
  • Neonatal Respiratory Health Research
  • Cardiovascular Issues in Pregnancy
  • Neonatal and fetal brain pathology
  • Pregnancy-related medical research
  • Birth, Development, and Health
  • COVID-19 and healthcare impacts
  • Preterm Birth and Chorioamnionitis
  • Vaccine Coverage and Hesitancy
  • Reproductive Health and Contraception
  • Ectopic Pregnancy Diagnosis and Management
  • Prenatal Screening and Diagnostics
  • Global Maternal and Child Health
  • Global Health Workforce Issues
  • Pregnancy and Medication Impact
  • Family and Patient Care in Intensive Care Units
  • Trauma and Emergency Care Studies

Washington University in St. Louis
2018-2025

Barnes-Jewish Hospital
2023-2024

Jewish Hospital
2023-2024

European Brain Council
2024

University of Puerto Rico at Carolina
2024

Community Link
2021-2023

American Diabetes Association
2023

Robert Wood Johnson Foundation
2023

MedStar Washington Hospital Center
2023

Cleveland Clinic
2023

The possible connection between coronavirus disease 2019 (COVID-19) and hypertensive disorders of pregnancy (HDP) remains unclear.1Adhikari E.H. Moreno W. Zofkie A.C. et al.Pregnancy outcomes among women with without severe acute respiratory syndrome 2 infection.JAMA Network Open. 2020; 3e2029256Crossref PubMed Scopus (159) Google Scholar Elucidating these is important both to better understand COVID-19 pathophysiology improve patient care in pregnant patients COVID-19. Our objectives were...

10.1016/j.ajog.2021.03.001 article EN other-oa American Journal of Obstetrics and Gynecology 2021-03-03

Importance Black pregnant patients are significantly more likely than their White counterparts to undergo peripartum urine drug screening (UDS) and subsequent reporting child protective services (CPS). Objective To evaluate the association of removing isolated cannabis use limited prenatal care as order indications, combined with clinician-facing clinical decision support, racial parity in UDS CPS reporting. Design, Setting, Participants This quality improvement study assessed 9396 at a...

10.1001/jamanetworkopen.2025.0908 article EN cc-by-nc-nd JAMA Network Open 2025-03-17

OBJECTIVE: To examine the association between pregnancy and medications for opioid use disorder (MOUD) initiation discontinuation among reproductive-aged people receiving treatment (OUD) in United States. METHODS: We conducted a retrospective cohort study of with gender recorded as female, aged 18–45 years, Merative TM MarketScan ® Commercial Multi-State Medicaid Databases (2006–2016). Opioid status were identified based on inpatient or outpatient claims established International...

10.1097/aog.0000000000005117 article EN Obstetrics and Gynecology 2023-03-09

Opioid use disorder (OUD) in pregnancy has significantly increased the last decade, impacting 8.2 per 1000 deliveries. OUD carries significant risk of morbidity and mortality for both birthing person neonate, but outcomes are improved with opioid agonist treatment (OAT). Here, we describe recommended forms OAT pregnancy, updates to literature, alternate strategies, share practical peripartum considerations patients on OAT.

10.1097/gco.0000000000000932 article EN Current Opinion in Obstetrics & Gynecology 2024-01-05

Introduction Patients with opioid use disorder may have difficulty transitioning from full-agonist opioids to sublingual buprenorphine due the risk of precipitated withdrawal. Novel strategies been developed facilitate this transition, including micro-dosing transdermal buprenorphine. We began using a transition strategy at our hospital in 2019.Methods performed retrospective observational cohort study patients treated (prescribed or recreational) while hospitalized between January 2019 and...

10.1080/15563650.2022.2028802 article EN Clinical Toxicology 2022-01-20

We performed a retrospective cohort study of all Type 1 cesarean scar pregnancies (n=18) or cervical (n=5) at an academic tertiary center after treatment with double balloon catheter from 2018 to 2022 evaluate outcomes and maternal morbidity. Cervical was associated no cases (95% confidence interval 0-16%) hemorrhage treated transfusion, hysterectomy, ICU admission. Treatment successfully by nine different obstetrics gynecology specialists.

10.1097/aog.0000000000004977 article EN Obstetrics and Gynecology 2022-11-03

Preterm birth is a leading cause of morbidity and mortality in newborns. Babies born prematurely are at increased risk lifelong health problems, including neurodevelopmental abnormalities. Cervical shortening precedes preterm many women. caused, part, by excessive softening the extracellular matrix (ECM) cervical stroma. In clinical obstetrics, prompts treatment with supplemental progesterone to prevent birth. However, progesterone-mediated effects on ECM not well understood. This research...

10.1089/ten.tea.2018.0036 article EN Tissue Engineering Part A 2018-06-01

ABSTRACT OBJECTIVE Evaluate associations between prenatal cannabis use (PCU) and perinatal outcomes. METHODS We performed an interval analysis of a prospective cohort study pregnant individuals with pre-pregnancy negative self-report nicotine use, comparing those who continued through pregnancy stopped. Patients underwent interviews urine drug screening for cotinine, metabolite, in each trimester. The primary outcome was small gestational age (SGA) at delivery. Secondary outcomes included...

10.1101/2024.03.29.24305025 preprint EN medRxiv (Cold Spring Harbor Laboratory) 2024-03-30

Using contraception to delay pregnancy allows people with opioid use disorder (OUD) choose when they are ready continue their families. Yet, postpartum contraceptive uptake among OUD has not been well characterized.

10.1016/j.dadr.2024.100248 article EN cc-by-nc Drug and Alcohol Dependence Reports 2024-06-24
Coming Soon ...